Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
CrossRef Ononin Inhibits the Growth and Metastasis of Hepatocellular Carcinoma by Suppressing MMP2 and MMP9 via PI3K/AKT/mTOR Signaling Shasha Peng, Jun Guo, Hongfei Fu Journal of Biochemical and Molecular Toxicology .2026;[Epub] CrossRef Global landscape of yttrium-90 clinical trials: a systematic registry-based analysis Qianwen Ni, Kenan Wang, Wenyi Jin, Yakun Gao, Ping Gong, Zhenguang Wang, Zheqi Xu, Hui Liu, Susu Luo Trials .2026;[Epub] CrossRef Artificial Intelligence and Radiomics in Primary Liver Cancer Imaging: A Bibliometric and Visualized Analysis Ruizhi Fu, Chen Gao, Xinjing Lou, Ziqing Han, Yizhen He, Chenye Zheng, Zhuping Yu, Hongsheng Chang Journal of Hepatocellular Carcinoma .2026
Timing considerations KLOW can be administered at any time of day, but most protocols recommend morning dosing
Firefly luciferase activity is normalized to the control Renilla luciferase activity
Das populaere 1:1-Verhaeltnis leitet sich aus der Pharmakologie der Einzelkomponenten und aus den GHRH-plus-GHRP-Synergiestudien ab, nicht aus einem direkten Kopf-an-Kopf-Vergleich der beiden Peptide
When used together, there may be an additive effect on heart rate , which could be clinically significant in patients with pre-existing cardiovascular conditions, including hypertension, arrhythmias, or coronary artery disease
US$ 20.41
US$ 27.60
US$ 27.29
US$ 20.01
US$ 27.88
